MRVI logo

MRVI

Profile

Full Name

Maravai LifeSciences Holdings, Inc.

Ticker Symbol

MRVI

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

November 20, 2020

Indexes

Not included

Website

http://www.maravai.com

Employees

570

Key Details

Price

$1.95

Market Cap

$279.40M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$259.19M(-10.30% YoY)

Annual EPS

-$1.05(-16.67% YoY)

PE Ratio

-

Next earnings date

May 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.95
MRVI price is $1.95

Price All-time High

$60.62
MRVI price is currently -96.79% below its historical high of $60.62

Price Today Change

-6.94%
MRVI price is down -6.94% today

Price YTD Change

-62.95%
MRVI price is down -62.95% since January 1st

Price 1-year Change

-76.42%
MRVI price is down -76.42% year-on-year

Price 3-year Change

-94.47%
MRVI price is down -94.47% over the past 3 years

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market Cap

$279.40M
MRVI market capitalization is $279.40 million

Market Cap 3-year Change

-93.95%
MRVI market capitalization is down -93.95% over the past 3 years

Market Cap All-time High

$6.93B
MRVI market capitalization is currently -95.97% below its historical high of $6.93 billion

Market Cap Sector Rank

62.92%
MRVI market capitalization is higher than 62.92% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+8.29%
MRVI shares outstanding is up +8.29% year-on-year

Shares Outstanding 3-Year Change

+9.25%
MRVI shares outstanding is up +9.25% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.02
MRVI beta is 1.02

200-day SMA

$6.36
MRVI price is currently -69.42% below its 200-day simple moving average

50-day SMA

$3.51
MRVI price is currently -44.58% below its 50-day simple moving average

RSI

28.19
MRVI 14-day relative strength index is 28.19

Volume

1.00
MRVI 30-day relative volume is 1.00

ATR

$0.20
MRVI average true range is $0.20

10-day Historical Volatility

55.44%
MRVI 10-day historical volatility is 55.44%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$259.19M
MRVI annual revenue is $259.19 million

Revenue Analysts Estimate

$192.78M
MRVI annual revenue is currently +34.44% higher than the consensus analysts' forecast

Revenue 1-year Change

-10.3%
MRVI annual revenue is down -10.3% year-on-year

Revenue Sector Rank

68.67%
MRVI annual revenue is higher than 68.67% of companies in Healthcare sector

EPS

EPS

-$1.05
MRVI annual earnings per share is -$1.05

EPS Analysts Estimate

-$0.26
MRVI annual earnings per share is currently +310.80% higher than the consensus analysts' forecast

EPS 1-year Change

-16.67%
MRVI annual earnings per share is down -16.67% year-on-year

EPS Sector Rank

55.8%
MRVI annual earnings per share is higher than 55.8% of companies in Healthcare sector

Profit

Gross Profit

$108.31M
MRVI annual gross profit is $108.31 million

Gross Margin

41.79%
MRVI annual gross profit margin is 41.79%

Operating Profit

-$72.68M
MRVI annual operating income is -$72.68 million

Operating Margin

-28.04%
MRVI annual operating profit margin is -28.04%

Net Income

-$144.85M
MRVI annual net profit is -$144.85 million

Net Margin

-55.89%
MRVI annual net profit margin is -55.89%

Expenses

Total Expenses

$331.87M
MRVI annual total expenses is $331.87 million

Operating Expenses

$180.99M
MRVI annual total operating expenses is $180.99 million

Cost Of Goods Sold

$150.88M
MRVI annual cost of goods sold is $150.88 million

Selling, General & Administrative Expenses

$161.77M
MRVI annual SGA is $161.77 million

Depreciation And Amortization

$56.87M
MRVI annual depreciation & amortization is $56.87 million

Interest Expense

$47.70M
MRVI annual interest expense is $47.70 million

Income Tax

-$1.86M
MRVI annual income tax is -$1.86 million

EBIT & EBITDA

EBIT

-$213.78M
MRVI annual earnings before interest & taxes is -$213.78 million

EBITDA

-$156.92M
MRVI annual EBITDA is -$156.92 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total Assets

$1.01B
MRVI annual total assets is $1.01 billion

Non Current Assets

$579.10M
MRVI annual long term assets is $579.10 million

Current Assets

$429.15M
MRVI annual total current assets is $429.15 million

Cash And Cash Equivalents

$322.40M
MRVI annual cash & cash equivalents is $322.40 million

Accounts Receivable

$38.52M
MRVI annual accounts receivable is $38.52 million

Inventory

$50.08M
MRVI annual inventory is $50.08 million

Liabilities

Total Liabilities

$431.04M
MRVI annual total liabilities is $431.04 million

Long Term Liabilities

$374.06M
MRVI annual total long term liabilities is $374.06 million

Current Liabilities

$56.97M
MRVI annual total current liabilities is $56.97 million

Accounts Payable

$11.96M
MRVI annual accounts payable is $11.96 million

Debt

Total Debt

$376.69M
MRVI annual total debt is $376.69 million

Total Debt 1-year Change

-38.34%
MRVI annual total debt is down -38.34% year-on-year

Long Term Debt

$362.98M
MRVI annual long term debt is $362.98 million

Short Term Debt

$13.71M
MRVI annual short term debt is $13.71 million

Equity & Capital

Shareholders Equity

$325.29M
MRVI annual stockholders equity is $325.29 million

Book Value

$325.29M
MRVI annual book value is $325.29 million

Retained Earnings

$140.89M
MRVI annual retained earnings is $140.89 million

Working Capital

$372.18M
MRVI annual working capital is $372.18 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash From Operations

$7.46M
MRVI annual cash flow from operations is $7.46 million

Cash From Operations 1-year Change

-94.09%
MRVI annual cash flow from operations is down -94.09% year-on-year

Cash From Investing

-$24.32M
MRVI annual cash flow from investing activities is -$24.32 million

Cash From Investing 1-year Change

+80.12%
MRVI annual cash flow from investing activities is up +80.12% year-on-year

Cash From Financing

-$235.71M
MRVI annual cash flow from financing activities is -$235.71 million

Cash From Financing 1-year Change

-285.84%
MRVI annual cash flow from financing activities is down -285.84% year-on-year

CAPEX

CAPEX

$31.16M
MRVI annual capital expenditures is $31.16 million

CAPEX 1-year Change

-52.47%
MRVI annual capital expenditures is down -52.47% year-on-year

Free Cash Flow

Free Cash Flow

-$23.69M
MRVI annual free cash flow is -$23.69 million

Free Cash Flow 1-year Change

-139.05%
MRVI annual free cash flow is down -139.05% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross Margin

41.79%
MRVI annual gross profit margin is 41.79%

Operating Margin

-28.04%
MRVI annual operating profit margin is -28.04%

Net Margin

-55.89%
MRVI annual net profit margin is -55.89%

ROA & ROE

ROA

-11.61%
MRVI annual return on assets is -11.61%

ROE

-21.19%
MRVI annual return on equity is -21.19%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
MRVI price to earnings ratio value is unknown

PE Ratio Sector Rank

-
MRVI price to earnings ratio is unknown

PB Ratio

PB Ratio

0.86
MRVI price to book ratio is 0.86

PB Ratio Sector Rank

42.61%
MRVI price to book ratio is higher than 42.61% of companies in Healthcare sector

PS Ratio

PS Ratio

1.08
MRVI price to sales ratio is 1.08

PS Ratio Sector Rank

29.58%
MRVI price to sales ratio is higher than 29.58% of companies in Healthcare sector

Enterprise value

Enterprise Value

$333.70M
MRVI enterprise value is $333.70 million

Enterprise Value Sector Rank

64.95%
MRVI enterprise value is higher than 64.95% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-2.13
MRVI EV/EBITDA is -2.13

EV/EBITDA Sector Rank

30.13%
MRVI EV/EBITDA is higher than 30.13% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current Ratio

7.53
MRVI annual current ratio is 7.53

Quick Ratio

6.65
MRVI annual quick ratio is 6.65

Leverage

Debt To Equity

0.91
MRVI annual debt to equity ratio is 0.91

Interest Coverage Ratio

-4.48
MRVI annual interest coverage ratio is -4.48

Risk & Stability

Piotroski F-Score

4
MRVI piotroski f-score is 4

Altman Z-Score

0.58
MRVI altman z-score is 0.58

Analyst ratings

Recent major analysts updates

Mar 25, 25 Morgan Stanley
Equal-Weight
Mar 21, 25 UBS
Neutral
Mar 3, 25 B of A Securities
Buy
Feb 26, 25 Baird
Neutral
Dec 5, 24 Goldman Sachs
Sell
Nov 14, 24 Wolfe Research
Peer Perform
Nov 8, 24 William Blair
Market Perform
Nov 8, 24 RBC Capital
Outperform
Nov 8, 24 Baird
Outperform
Oct 8, 24 Goldman Sachs
Neutral

Institutional Ownership

Similar stocks

AURA logo
Aura Biosciences (AURA)
TRDA logo
Entrada Therapeutics (TRDA)
HCAT logo
Health Catalyst (HCAT)
SANA logo
Sana Biotechnology (SANA)
VSTM logo
Verastem (VSTM)
RIGL logo
Rigel Pharmaceuticals (RIGL)
RGC logo
Regencell Bioscience Holdings Limited (RGC)
ATXS logo
Astria Therapeutics (ATXS)
Rapport Therapeutics (RAPP)
  • What is the ticker symbol for Maravai LifeSciences Holdings?
  • Does Maravai LifeSciences Holdings pay dividends?
  • What sector is Maravai LifeSciences Holdings in?
  • What industry is Maravai LifeSciences Holdings in?
  • What country is Maravai LifeSciences Holdings based in?
  • When did Maravai LifeSciences Holdings go public?
  • Is Maravai LifeSciences Holdings in the S&P 500?
  • Is Maravai LifeSciences Holdings in the NASDAQ 100?
  • Is Maravai LifeSciences Holdings in the Dow Jones?
  • When was Maravai LifeSciences Holdings's last earnings report?
  • When does Maravai LifeSciences Holdings report earnings?
  • Should I buy Maravai LifeSciences Holdings stock now?

What is the ticker symbol for Maravai LifeSciences Holdings?

The ticker symbol for Maravai LifeSciences Holdings is NASDAQ:MRVI

Does Maravai LifeSciences Holdings pay dividends?

No, Maravai LifeSciences Holdings does not pay dividends

What sector is Maravai LifeSciences Holdings in?

Maravai LifeSciences Holdings is in the Healthcare sector

What industry is Maravai LifeSciences Holdings in?

Maravai LifeSciences Holdings is in the Biotechnology industry

What country is Maravai LifeSciences Holdings based in?

Maravai LifeSciences Holdings is headquartered in United States

When did Maravai LifeSciences Holdings go public?

Maravai LifeSciences Holdings's initial public offering (IPO) was on November 20, 2020

Is Maravai LifeSciences Holdings in the S&P 500?

No, Maravai LifeSciences Holdings is not included in the S&P 500 index

Is Maravai LifeSciences Holdings in the NASDAQ 100?

No, Maravai LifeSciences Holdings is not included in the NASDAQ 100 index

Is Maravai LifeSciences Holdings in the Dow Jones?

No, Maravai LifeSciences Holdings is not included in the Dow Jones index

When was Maravai LifeSciences Holdings's last earnings report?

Maravai LifeSciences Holdings's most recent earnings report was on Mar 18, 2025

When does Maravai LifeSciences Holdings report earnings?

The next expected earnings date for Maravai LifeSciences Holdings is May 8, 2025

Should I buy Maravai LifeSciences Holdings stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page